For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Commissioner details sorry saga of patients treated by Southern DHB urology services
+Print Archive
News
Commissioner details sorry saga of patients treated by Southern DHB urology services
Wednesday 6 November 2019, 03:00 AM

Failure to follow up a rapidly rising PSA level led to delayed treatment for one man’s prostate cancer and the subsequent development of secondary cancer
A recent decision from the health and disability commissioner contained details of four cases in which patients were poorly treated by the Southern DHB urology services and sheds light on issues confronting the service. Virginia McMillan reports
His wife rang [a DHB nurse] to question why his referral had been given such a low priority given the GP’s referral, and his wife was told that the op
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.